日韩高清,高清无码不卡在线观看,91精品美女,成人性视频高清一区二区三区不卡

On October 29, representatives of the Alberta Provincial Government of Canada, Mr. Ding Yifan and Ms. Luo Ying, visited Bio-S Pharmaceutical for inspection and exchange, accompanied by Bio-S Pharmaceutical Chairman and General Manager Lou Jinfang and relevant personnel.

Accompanied by the Bio-S Pharmaceutical team, Mr. Ding Yifan and his delegation visited the Bio-S Enterprise Exhibition Hall and the Impurity Research & Analysis Testing Center, and held discussions.

At the symposium, Mr. Lou introduced the R&D platform of Bio-S Pharmaceutical for veterinary drugs and health products. Bio-S Pharmaceutical has developed veterinary drugs including chemical generic drugs, Chinese veterinary preparations, human-to-veterinary drugs, and innovative veterinary drugs. In addition to veterinary drug research and development, Bio-S Pharmaceutical continues to make efforts in the field of big health products. Relying on the core technological advantages, perfect technical platform and efficient industrial transformation capabilities of Bio-S Macau Company in the field of big health product research and development, the company's commercialization system has been effectively extended in overseas markets, seizing new opportunities for global research and development of big health products.

Mr. Ding Yifan introduced Alberta's agricultural product resources and development potential, and said that Alberta is rich in natural resources, and the agriculture and food industries are important pillars of its economy, continuously providing high-quality products to the global market. Mr. Ding Yifan emphasized that Alberta has always attached importance to international cooperation, has strong policy support, and has a positive attitude towards cooperation with overseas partners. He hopes to work with excellent companies such as Bio-S Pharmaceutical in the future to expand the Asia-Pacific and even global markets and jointly promote economic development and innovative cooperation between the two sides.

In the subsequent exchanges, the two sides discussed in depth the possibility of future cooperation, exchanged views on key areas such as cross-border market access and complementary resource advantages, and jointly explored effective ways to advance bilateral relations.

The successful holding of this symposium not only built a bridge for cooperation between Bio-S Pharmaceutical and Alberta, Canada, but also injected new impetus into the company's future development in the field of veterinary medicine and health product research and development. I believe that with the joint efforts of both parties, a broader market space and cooperation prospects will be created.